An ADME study of [14C]AZD4604 and the Absolute Bioavailability of AZD4604

Trial Identifier:	D8210C00004
Sponsor:	AstraZeneca
Collaborator:	Quotient Sciences Limited
Start Date:	February 2024
Primary Completion Date:	May 2024
Study Completion Date:	May 2024
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
GB	Ruddington, GB, NG11 6JS

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.